Since I think it’s a safe bet that not many of you regularly read The Bulletin newspaper of Bend, Oregon, I suggest you read a two-part series by Markian Hawryluk as just one indication of the difference one individual can make, no matter the size of the news organization.
In part one, “Robot surgery is here to stay,” he discusses important issues of the marketing blitz for robotic surgery, a lack of data, and a long learning curve for surgeons.
In part two, “Robotic surgery may raise costs,” he explains how there are incentives for doctors to do robotic surgery because Medicare pays them more for that than for traditional open surgery.
A new twist on the marketing blitz: the marketing department of a New Jersey hospital system, CarePoint Health, sent out a news release, announcing:
CarePoint Health is pleased to present the opening event in the Dine and Discover free dinner and lecture series. Dr. Daniel Smith will give a presentation on the da Vinci Robot System. The community is invited for dinner and a fascinating evening to learn how state-of-the-art technology is revolutionizing health care in our region. Dr. Smith leads a groundbreaking surgical initiative at CarePoint Health Christ Hospital where the da Vinci Robot is being used to perform minimally invasive surgery for the first time in Hudson County. He will speak about his pioneering work in robotic surgery and answer questions about how this new technology will change the future of health care.
When you visit the CarePoint website, you find promotion of “Groundbreaking Robotic Surgery Performed for the First Time in Hudson County.” One of the two “pioneering” surgeries was a robotic hysterectomy.
Last year, the American College of Obstetricians and Gynecologists warned:
“Robotic surgery is not the only or the best minimally invasive approach for hysterectomy. Nor is it the most cost-efficient. It is important to separate the marketing hype from the reality when considering the best surgical approach for hysterectomies. … Aggressive direct-to-consumer marketing of the latest medical technologies may mislead the public into believing that they are the best choice. Our patients deserve and need factual information about all of their treatment options, including costs, so that they can make truly informed health care decisions.”
And hysterectomy was the focus as another DaVinci robotic surgery system ad campaign appeared. Former hospital CEO Paul Levy, a frequent critic of DaVinci marketing and proliferation, was on the attack again. Excerpt:
“But now the market for prostate surgery is saturated, so it’s time to move to another type of surgery that raises anxiety, this one for women. Hysterectomies are the target. Again, let’s use the heartfelt comments of patients to support the cause, while being soft on scientifically valid clinical studies.”
Stay tuned for the next robot roundup. Given the trends in the industry, it won’t be long.
Addendum: I almost forgot this one. Fox News reports that the first robotic surgery institute in the Caribbean has been opened in the Dominican Republic. And it’s named after Fox News “Medical A Team” contributor Dr. David Samadi, who often touts robotic surgery on the air. Excerpt of the story:
“This is a huge step in this country and it’s going to bring a lot of patients from the entire Caribbean to this hospital,” Samadi said.
And beyond the Caribbean, with more and more regulations and restrictions coming our way on American soil, many patients will look elsewhere for their surgeries. The new David Samadi Robotic Institute is one of the places they will be looking.
With a robot on every corner in the U.S., I wouldn’t hold my breath about Americans going to the DR for a Samadi special.
———————
Follow us on Twitter:
https://twitter.com/garyschwitzer
https://twitter.com/healthnewsrevu
Comments
Please note, comments are no longer published through this website. All previously made comments are still archived and available for viewing through select posts.
Comments are closed.
Our Comments Policy
But before leaving a comment, please review these notes about our policy.
You are responsible for any comments you leave on this site.
This site is primarily a forum for discussion about the quality (or lack thereof) in journalism or other media messages (advertising, marketing, public relations, medical journals, etc.) It is not intended to be a forum for definitive discussions about medicine or science.
We will delete comments that include personal attacks, unfounded allegations, unverified claims, product pitches, profanity or any from anyone who does not list a full name and a functioning email address. We will also end any thread of repetitive comments. We don”t give medical advice so we won”t respond to questions asking for it.
We don”t have sufficient staffing to contact each commenter who left such a message. If you have a question about why your comment was edited or removed, you can email us at feedback@healthnewsreview.org.
There has been a recent burst of attention to troubles with many comments left on science and science news/communication websites. Read “Online science comments: trolls, trash and treasure.”
The authors of the Retraction Watch comments policy urge commenters:
We”re also concerned about anonymous comments. We ask that all commenters leave their full name and provide an actual email address in case we feel we need to contact them. We may delete any comment left by someone who does not leave their name and a legitimate email address.
And, as noted, product pitches of any sort – pushing treatments, tests, products, procedures, physicians, medical centers, books, websites – are likely to be deleted. We don”t accept advertising on this site and are not going to give it away free.
The ability to leave comments expires after a certain period of time. So you may find that you’re unable to leave a comment on an article that is more than a few months old.
You might also like